Pages that link to "Q47194413"
Jump to navigation
Jump to search
The following pages link to The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. (Q47194413):
Displaying 15 items.
- Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes (Q47165661) (← links)
- Metabolic Syndrome and Antipsychotics: The Role of Mitochondrial Fission/Fusion Imbalance. (Q55231596) (← links)
- Centrally Acting Agents for Obesity: Past, Present, and Future (Q57177981) (← links)
- A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia (Q59789965) (← links)
- Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia (Q60302511) (← links)
- Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis (Q64063469) (← links)
- Effects of Olanzapine on Bone Mineral Density, Glucose, and Lipid Metabolism in Schizophrenia Patients (Q64065737) (← links)
- Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters show stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slo (Q89598505) (← links)
- Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs (Q89964094) (← links)
- Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain (Q90198208) (← links)
- Preclinical and Clinical Sex Differences in Antipsychotic-Induced Metabolic Disturbances: A Narrative Review of Adiposity and Glucose Metabolism (Q90294280) (← links)
- Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial (Q90430285) (← links)
- Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5-HT2c receptor-NPY pathway (Q92270774) (← links)
- Association Between Antipsychotic Medication Use and Diabetes (Q93065943) (← links)
- Safety and Effectiveness of Lurasidone in Adolescents with Schizophrenia: Results of a 2-Year, Open-Label Extension Study (Q100736090) (← links)